Erbstatin is a novel inhibitor of the EGF receptor-associated tyrosine kinase. It is an unstable compound and is completely inactivated in serum in 30 minutes. Methyl 2,5-dihydroxycinnamate is a stable erbstatin analog retaining activity after a 60 minute incubation. It inhibits EGF receptor-associated tyrosine kinase in vitro (IC50=0.77 µM). Inhibition is competitive with substrate and noncompetitive with ATP.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Regulatory Status |
RUO – Research Use Only |
---|